Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $5.1 Million Public Offering

Press Release – New York, NY – July 20, 2020 – Sichenzia Ross Ference LLP today announced that it represented Genetic Technologies Limited (NASDAQ: GENE), a leader in the development of genetic risk assessment tests, in a registered direct offering of 1,025,000 American Depositary Shares (the “ADSs”), each representing six hundred of the Company’s ordinary shares, at a purchase price of $5.00 per ADS, for gross proceeds of $5.1 million.

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

The offering was made pursuant to a shelf registration statement on Form F-3 (File No. 333-237152), previously filed with and declared effective by the U.S. Securities and Exchange Commission on March 13, 2020, and March 23, 2020, respectively.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Darrin Ocasio, and Avital Perlman, counsel Jeffrey Cahlon, and associate Yian Pan.

Author
Recent Posts

Sichenzia Ross Ference Carmel LLP

Sichenzia Ross Ference Carmel LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRFC’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRFC's LinkedIn page

Latest posts by Sichenzia Ross Ference Carmel LLP (see all)

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited in $5.1 Million Public Offering

Related Posts